Clinical Trial to Assess the Efficacy and Safety of YYD601 in the Treatment of Esophageal Reflux Disease (ERD)

Clinical trial NCT03943992 · COMPLETED

Trial details

NCT number: NCT03943992
Sponsor: Yooyoung Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Erosive Esophagitis

Start date: 2019-01-29
Primary completion: 2020-01-31
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.